Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8+ T cells does not improve their tumour infiltration in a mouse model of cancer but promotes the retention of these cells in tumour-draining lymph nodes

[1] Caspi RR(2008)Immunotherapy of autoimmunity and cancer: the penalty for success Nat Rev Immunol 8 970-976

[2] Mellman I(2011)Cancer immunotherapy comes of age Nature 480 480-489

[3] Coukos G(2016)Recent advances in understanding antitumor immunity F1000Res 5 2545-584

[4] Dranoff G(2016)Cancer immunotherapy: killers on sterols Nature 531 583-675

[5] Munhoz RR(2003)Adoptive-cell-transfer therapy for the treatment of patients with cancer Nat Rev Cancer 3 666-83

[6] Postow MA(2005)Adoptive T cell therapy: addressing challenges in cancer immunotherapy J Transl Med 3 17-231

[7] Dustin ML(2013)Elevated CD3 J Neuroimmunol 264 71-361

[8] Dudley ME(2013) and CD8 Am J Clin Oncol 36 224-751

[9] Rosenberg SA(2007) tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level Cancer Res 67 354-62

[10] Yee C(2008)Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer J Immunother 31 742-7130

[1] Caspi RR(2008)Immunotherapy of autoimmunity and cancer: the penalty for success Nat Rev Immunol 8 970-976

[2] Mellman I(2011)Cancer immunotherapy comes of age Nature 480 480-489

[3] Coukos G(2016)Recent advances in understanding antitumor immunity F1000Res 5 2545-584

[4] Dranoff G(2016)Cancer immunotherapy: killers on sterols Nature 531 583-675

[5] Munhoz RR(2003)Adoptive-cell-transfer therapy for the treatment of patients with cancer Nat Rev Cancer 3 666-83

[6] Postow MA(2005)Adoptive T cell therapy: addressing challenges in cancer immunotherapy J Transl Med 3 17-231

[7] Dustin ML(2013)Elevated CD3 J Neuroimmunol 264 71-361

[8] Dudley ME(2013) and CD8 Am J Clin Oncol 36 224-751

[9] Rosenberg SA(2007) tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level Cancer Res 67 354-62

[10] Yee C(2008)Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer J Immunother 31 742-7130